US2009291491A1PendingUtilityA1

Retroviral vectors

Assignee: KINGSMAN ALAN JOHNPriority: Oct 17, 1996Filed: Sep 30, 2008Published: Nov 26, 2009
Est. expiryOct 17, 2016(expired)· nominal 20-yr term from priority
C12N 2740/16052C12N 2740/15043A61K 48/00C12N 2740/16043C12N 2740/15052C12N 15/86A61K 48/0091
64
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Retroviral vector production systems for producing lentivirus-based vector particles which are capable of infecting and transducing non-dividing target cells, wherein one or more of the auxiliary genes such as vpr, vif, tat, and nef in the case of HIV-1 are absent from the system. The systems and resulting retrovirus vector particles have improved safety over existing systems and vectors.

Claims

exact text as granted — not AI-modified
1 - 38 . (canceled) 
     
     
         39 . A retroviral vector capable of infecting and transducing a cell, wherein the retroviral vector is lentivirus-based and wherein one or more auxiliary genes chosen from the HIV-1 auxiliary genes vpr; vif, tat and nef or from the analogous auxiliary genes of other lentivirus, which auxiliary genes are normally present in the lentivirus on which the retroviral vector is based, is or are absent from the retroviral vector.

Join the waitlist — get patent alerts

Track US2009291491A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.